Long-term results for patients with unresectable gastric cancer who received chemotherapy in the Japan Clinical Oncology Group (JCOG) trials

[1]  S. Pyrhönen,et al.  Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. , 1995, British Journal of Cancer.

[2]  U. Haglund,et al.  Initial or delayed chemotherapy with best supportive care in advanced gastric cancer. , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  S. Yoshida,et al.  A phase II study of combination therapy with 5′‐deoxy‐5‐fluorouridine and cisplatin in the treatment of advanced gastric cancer with primary foci , 1993, Cancer.

[4]  A. Petroianu,et al.  Modified therapy with 5‐fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer , 1993, Cancer.

[5]  S. Yoshida,et al.  A Cooperative Randomized Study on Tegafur plus Mitomycin C versus Combined Tegafur and Uracil plus Mitomycin C in the Treatment of Advanced Gastric Cancer , 1991, Japanese journal of cancer research : Gann.

[6]  M. Yasutomi,et al.  [A case report of long-term survival in advanced gastric cancer with multiple liver metastases treated with mitomycin C and tegafur therapy after palliative gastrectomy]. , 1988, Gan to kagaku ryoho. Cancer & chemotherapy.

[7]  S. Masuda,et al.  [A long-surviving case of gastric cancer with liver metastasis without signs of recurrence for six years after palliative operation]. , 1987, Gan no rinsho. Japan journal of cancer clinics.

[8]  L. Heilbrun,et al.  The natural history of gastric cancer and prognostic factors influencing survival. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  Moertel Cg.  The natural history of advanced gastric cancer. , 1968 .

[10]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[11]  A. Ohtsu,et al.  Phase II study of protracted infusional 5-fluorouracil combined with cisplatinum for advanced gastric cancer: report from the Japan Clinical Oncology Group (JCOG). , 1994, European journal of cancer.

[12]  C. Moertel.  The natural history of advanced gastric cancer. , 1968, Surgery, gynecology & obstetrics.